Clinical Trial Update: Yunzhi as Dietary Supplement in Breast Cancer [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial evaluating Yunzhi as a dietary supplement for breast cancer, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Yunzhi

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Breast Cancer | Phase 4 | Status: UNKNOWN